Bone cancer (sarcoma) - Clinical trials 

  • Clinical trials

Clinical trials for Bone cancer (sarcoma)

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bone cancer (sarcoma). For all clinical trials, go to clinical trials search

This list shows clinical trials for Bone cancer (sarcoma)

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bone cancer (sarcoma)
Title Recruitment status Location
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma Recruiting United Kingdom
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer Recruiting United Kingdom
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Recruiting United Kingdom
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy Recruiting United Kingdom
A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic - D4320C00014 Not Recruiting United Kingdom
Phase 2 single-arm studies of Gemcitabine in combination with Oxaliplatin in refractory and relapsed pediatric solid tumors - ITCC-004-GEMOX Not Recruiting United Kingdom
Chemotherapy for Patients With Osteosarcoma Not recruiting United Kingdom
A Study to Determine the Activity of SCH 717454 in Subjects With Osteosarcoma or Ewing’s Sarcoma That Has Relapsed After Standard Systemic Therapy. - P04720 Not Recruiting United Kingdom
A phase II, randomised, double-blind, parallel-group, placebo-controlled, multi-centre study to assess the efficacy and safety of once-daily orally administered ZD4054 15 mg and 10 mg doses in pain-free or mildly symptomatic patients with prostate cancer and bone metastases, who have rising serum prostate specific antigen (PSA) levels despite medical or surgical castration - EPOC Not Recruiting United Kingdom
A randomised trial of chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) in operable osteosarcoma Not recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member